Biography
Wassil Nowicky is working as the Director of Nowicky Pharma and the President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). He has finished his studies at the Radiotechnical Faculty of the Technical University of Lviv (Ukraine) at the end of 1955 with graduation to “Diplomingeniueur†in 1960 which title was nostrificated in Austria in 1975. He is the Inventor of the anticancer preparation on basis of celandine alkaloids “NSC-631570â€. He is the Author of over 300 scientific articles dedicated to cancer research. He is a Real Member of the New York Academy of Sciences, Member of the European Union for Applied Immunology and of the American Association for Scientific Progress, Honorary Doctor of the Janka Kupala University in Hrodno, Doctor “Honoris Causa†of the Open International University on Complex Medicine in Colombo, Honorary Member of the Austrian Society of a name od Albert Schweizer. He has received the award of merits from National Guild of Pharmacists of America, the Award of Austrian Society of Sanitary, Hygiene and Public Health Services and others.
Research Interest
Oncology
Biography
Liane Deligdisch graduated Medical School in Bucharest, Romania. Following positions were: Gynecologist and General Physician in Romania until 1963, Pathologist at the Ichilov Hospital, Tel Aviv Medical School, Israel 1963 to 1975, Visiting Professor Magee Women Hospital in Pittsburgh, Pa.; 1975-6 Boston Free Hospital for Women, Harvard Medical School ; 1976 to present The Mount Sinai School of Medicine, full Professor of Pathology and Obstetrics-Gynecology and Attending since 1986. Founded the division of Gynecologic Pathology and directed the course of Gynecologic Pathology at the Medical School, Authored 143 peer reviewed articles , 7 textbooks on Gynecologic Pathology.
Research Interest
Gynecology, Obstetrics-Gynecology, Gynecologic Pathology
Biography
Dr Michael J Sinosich established the Division of Prenatal Testing within Sonic Clinical Institute in 2002. Michael is an internationally respected investigator in early pregnancy well-being. He has published extensively in peer reviewed journals and presented numerous papers at local, national and international forums. The focus of Michael’s research has been his work on Pregnancy-Associated Plasma Protein-A (PAPP– A). Michael launched his investigations on PAPP-A in 1980 and his early clinical studies established PAPP-A as a biochemical marker with immense clinical potential 1-3. These studies have subsequently been independently substantiated and his vision of early pregnancy screening is now an established reality
Research Interest
Prenatal Screening